Risk of non-Hodgkin lymphoma in breast cancer survivors: a nationwide cohort study - Summary - MDSpire

Risk of non-Hodgkin lymphoma in breast cancer survivors: a nationwide cohort study

  • By

  • Danbee Kang

  • Sang Eun Yoon

  • Dongwook Shin

  • Jin Lee

  • Yun Soo Hong

  • Se Kyung Lee

  • Jeong Eon Lee

  • Yeon Hee Park

  • Jin Seok Ahn

  • Eliseo Guallar

  • Won Seog Kim

  • Jungho Lee

  • Seok Jin Kim

  • Juhee Cho

  • December 14, 2021

  • 0 min

Share

Objective:

To evaluate the incidence of non-Hodgkin lymphoma (NHL) in breast cancer survivors using a nationwide cohort, highlighting its significance in understanding long-term health risks.

Key Findings:
  • Breast cancer survivors showed a higher incidence of NHL compared to the general population, with specific rates to be detailed.
  • The study identified specific NHL subtypes associated with breast cancer treatment modalities.
Interpretation:

The findings suggest a potential link between breast cancer and increased risk of NHL, highlighting the need for further research into the underlying mechanisms and implications for patient care.

Limitations:
  • The study relied on claims data, which may have limitations in accuracy and completeness, potentially affecting the reliability of findings.
  • Potential confounding factors such as lifestyle variables and detailed treatment regimens were not fully explored, which could influence the results.
Conclusion:

Breast cancer survivors may be at an elevated risk for developing NHL, warranting closer monitoring and further investigation into the relationship between breast cancer treatments and NHL incidence.

Original Source(s)

Risk of non-Hodgkin lymphoma in breast cancer survivors: a nationwide cohort study

  • by Danbee Kang, Sang Eun Yoon, Dongwook Shin, Jin Lee, Yun Soo Hong, Se Kyung Lee, Jeong Eon Lee, Yeon Hee Park, Jin Seok Ahn, Eliseo Guallar, Won Seog Kim, Jungho Lee, Seok Jin Kim, Juhee Cho

  • December 14, 2021

Related Content

Roswell Park is Hiring!

Working at Roswell Park will afford you incredible opportunities to work alongside some of the nation’s foremost clinicians and researchers to broaden your career experiences and be part of a team that eases the burden of cancer.

  • by

  • May 19, 2025

  • 1 min
Pathology Clinics: Bringing the Lab out of the Basement

As new ASCP guidelines are issued for pathology clinics, we hear from patients who can vouch for their benefits

Dana-Farber Research News 02.15.2026

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from January 16 - 31.

  • by

  • February 15, 2026

  • 21 min